The Global Vaccine Safety Initiative: enhancing vaccine pharmacovigilance capacity at country level

Large-scale immunization programmes now extend to all parts of the world, including least developed countries, where they reach unprecedented numbers of people. The number of vaccine doses administered worldwide continues to increase as new vaccines are developed and made available, and more people...

Full description

Saved in:
Bibliographic Details
Published in:Bulletin of the World Health Organization 2014-09, Vol.92 (9), p.695-696
Main Authors: MAURE, Christine G, DODOO, Alexander N, BONHOEFFER, Jan, ZUBER, Patrick L. F
Format: Article
Language:English
Subjects:
Adverse Drug Reaction Reporting Systems
Biological and medical sciences
Collaboration
Communities
Diseases
Dosage and administration
General aspects
Global Health
Health
Health surveillance
High income
Humans
Hypothesis testing
Immunization
Immunization Programs
Medical sciences
Miscellaneous
Patient Safety
Pharmacovigilance
Prevention and actions
Product safety
Public health
Public health. Hygiene
Public health. Hygiene-occupational medicine
Quality management
Regulation
Safety
Strategy
Strengthening
Studies
Surveillance
Vaccines
Vaccines - standards
Working groups
World Health Organization
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c806t-adfc2fc53267507909d812962702cfe47992ecc8da088617c269686a25b657853
cites cdi_FETCH-LOGICAL-c806t-adfc2fc53267507909d812962702cfe47992ecc8da088617c269686a25b657853
container_end_page 696
container_issue 9
container_start_page 695
container_title Bulletin of the World Health Organization
container_volume 92
creator MAURE, Christine G
DODOO, Alexander N
BONHOEFFER, Jan
ZUBER, Patrick L. F
description Large-scale immunization programmes now extend to all parts of the world, including least developed countries, where they reach unprecedented numbers of people. The number of vaccine doses administered worldwide continues to increase as new vaccines are developed and made available, and more people have access to immunization services. Development of immunization programmes in low- and middle-income countries (LMIC) has increased immunization coverage, which in turn has led to a reduction in vaccine-preventable diseases. However, as vaccine use has increased in LMICs, so has public attention to vaccine safety issues, as happened previously in high-income countries. The Decade of Vaccines aims to increase coordination within the vaccine community worldwide. The Global Vaccine Action Plan includes a vaccine safety strategy, the Global Vaccine Safety Blueprint. Capacity development at country level is the main guiding principle of the Global Vaccine Safety Initiative. The initiative is aligned with other related WHO capacity-building efforts, including the strengthening of immunization programmes and national regulatory authorities.
doi_str_mv 10.2471/BLT.14.138875
format article
fullrecord <record><control><sourceid>gale_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_319fa592bb9041bd85e869e40edc8479</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A387347353</galeid><doaj_id>oai_doaj_org_article_319fa592bb9041bd85e869e40edc8479</doaj_id><sourcerecordid>A387347353</sourcerecordid><originalsourceid>FETCH-LOGICAL-c806t-adfc2fc53267507909d812962702cfe47992ecc8da088617c269686a25b657853</originalsourceid><addsrcrecordid>eNqNk81v00AQxS0EoqVw5IosIRAcEnbX-9kDUqmgRFQC0cB1NVmPna0cb_DaEfnv2ZDQNigS2AdLM7956zerl2VPKRkzruibd5fTMeVjWmitxL3smArJR0QSfj87JoSzkZFaHmWPYrwm6TGcPMyOmCiUVpIdZ246x_yiCTNo8u_gnG8xv4IK-3U-aX3vofcrPM2xnUObmnW-2kHLOXQLcGHla9-kHuYOluB8GoQ-d2Fo-26dN7jC5nH2oIIm4pPd9yT79uH99Pzj6PLzxeT87HLkNJH9CMrKscqJgkkliDLElJoyI5kizFXIlTEMndMlEK0lVY7JjTdgYiaF0qI4ySZb3TLAtV12fgHd2gbw9nchdLWFrveuQVtQU4EwbDYzhNNZqQVqaZATLJ1OJyWtt1ut5TBbpCImO9Dsie53Wj-3dVhZzogWSiWBVzuBLvwYMPZ24aPDJu0KwxAtlcwUimpa_BsVyS5RmtCEPv8LvQ5D16atJirthGshzS1VQ_Lq2yqkX3QbUXtWaFVwVYjNsaMDVI0tJj-hxcqn8h4_PsCnt8SFdwcHXu8NJKbHn30NQ4z205fJf7OTq6_77Ms77Byh6ecxNEPvQxsPOnRdiLHD6ub-KLGb9NiUHku53aYn8c_uXvoN_ScuCXixAyA6aKpuE4p4y2nNtKCk-AVirRwW</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1561748569</pqid></control><display><type>article</type><title>The Global Vaccine Safety Initiative: enhancing vaccine pharmacovigilance capacity at country level</title><source>International Bibliography of the Social Sciences (IBSS)</source><source>Social Science Premium Collection</source><source>ABI/INFORM Global</source><source>Politics Collection</source><source>PAIS Index</source><source>PubMed Central</source><creator>MAURE, Christine G ; DODOO, Alexander N ; BONHOEFFER, Jan ; ZUBER, Patrick L. F</creator><creatorcontrib>MAURE, Christine G ; DODOO, Alexander N ; BONHOEFFER, Jan ; ZUBER, Patrick L. F</creatorcontrib><description>Large-scale immunization programmes now extend to all parts of the world, including least developed countries, where they reach unprecedented numbers of people. The number of vaccine doses administered worldwide continues to increase as new vaccines are developed and made available, and more people have access to immunization services. Development of immunization programmes in low- and middle-income countries (LMIC) has increased immunization coverage, which in turn has led to a reduction in vaccine-preventable diseases. However, as vaccine use has increased in LMICs, so has public attention to vaccine safety issues, as happened previously in high-income countries. The Decade of Vaccines aims to increase coordination within the vaccine community worldwide. The Global Vaccine Action Plan includes a vaccine safety strategy, the Global Vaccine Safety Blueprint. Capacity development at country level is the main guiding principle of the Global Vaccine Safety Initiative. The initiative is aligned with other related WHO capacity-building efforts, including the strengthening of immunization programmes and national regulatory authorities.</description><identifier>ISSN: 0042-9686</identifier><identifier>EISSN: 1564-0604</identifier><identifier>DOI: 10.2471/BLT.14.138875</identifier><identifier>PMID: 25378762</identifier><identifier>CODEN: BWHOA6</identifier><language>eng</language><publisher>Genève: Organisation mondiale de la santé</publisher><subject>Adverse Drug Reaction Reporting Systems ; Biological and medical sciences ; Collaboration ; Communities ; Diseases ; Dosage and administration ; General aspects ; Global Health ; Health ; Health surveillance ; High income ; Humans ; Hypothesis testing ; Immunization ; Immunization Programs ; Medical sciences ; Miscellaneous ; Patient Safety ; Pharmacovigilance ; Prevention and actions ; Product safety ; Public health ; Public health. Hygiene ; Public health. Hygiene-occupational medicine ; Quality management ; Regulation ; Safety ; Strategy ; Strengthening ; Studies ; Surveillance ; Vaccines ; Vaccines - standards ; Working groups ; World Health Organization</subject><ispartof>Bulletin of the World Health Organization, 2014-09, Vol.92 (9), p.695-696</ispartof><rights>2015 INIST-CNRS</rights><rights>COPYRIGHT 2014 World Health Organization</rights><rights>Copyright World Health Organization Sep 2014</rights><rights>(c) 2014 The authors; licensee World Health Organization. 2014</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c806t-adfc2fc53267507909d812962702cfe47992ecc8da088617c269686a25b657853</citedby><cites>FETCH-LOGICAL-c806t-adfc2fc53267507909d812962702cfe47992ecc8da088617c269686a25b657853</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/1561748569/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$H</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/1561748569?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>230,314,727,780,784,885,11688,12847,21387,21394,27866,27924,27925,33223,33224,33611,33612,33985,33986,36060,36061,43733,43948,44363,53791,53793,74221,74468,74895</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=28828510$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25378762$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>MAURE, Christine G</creatorcontrib><creatorcontrib>DODOO, Alexander N</creatorcontrib><creatorcontrib>BONHOEFFER, Jan</creatorcontrib><creatorcontrib>ZUBER, Patrick L. F</creatorcontrib><title>The Global Vaccine Safety Initiative: enhancing vaccine pharmacovigilance capacity at country level</title><title>Bulletin of the World Health Organization</title><addtitle>Bull World Health Organ</addtitle><description>Large-scale immunization programmes now extend to all parts of the world, including least developed countries, where they reach unprecedented numbers of people. The number of vaccine doses administered worldwide continues to increase as new vaccines are developed and made available, and more people have access to immunization services. Development of immunization programmes in low- and middle-income countries (LMIC) has increased immunization coverage, which in turn has led to a reduction in vaccine-preventable diseases. However, as vaccine use has increased in LMICs, so has public attention to vaccine safety issues, as happened previously in high-income countries. The Decade of Vaccines aims to increase coordination within the vaccine community worldwide. The Global Vaccine Action Plan includes a vaccine safety strategy, the Global Vaccine Safety Blueprint. Capacity development at country level is the main guiding principle of the Global Vaccine Safety Initiative. The initiative is aligned with other related WHO capacity-building efforts, including the strengthening of immunization programmes and national regulatory authorities.</description><subject>Adverse Drug Reaction Reporting Systems</subject><subject>Biological and medical sciences</subject><subject>Collaboration</subject><subject>Communities</subject><subject>Diseases</subject><subject>Dosage and administration</subject><subject>General aspects</subject><subject>Global Health</subject><subject>Health</subject><subject>Health surveillance</subject><subject>High income</subject><subject>Humans</subject><subject>Hypothesis testing</subject><subject>Immunization</subject><subject>Immunization Programs</subject><subject>Medical sciences</subject><subject>Miscellaneous</subject><subject>Patient Safety</subject><subject>Pharmacovigilance</subject><subject>Prevention and actions</subject><subject>Product safety</subject><subject>Public health</subject><subject>Public health. Hygiene</subject><subject>Public health. Hygiene-occupational medicine</subject><subject>Quality management</subject><subject>Regulation</subject><subject>Safety</subject><subject>Strategy</subject><subject>Strengthening</subject><subject>Studies</subject><subject>Surveillance</subject><subject>Vaccines</subject><subject>Vaccines - standards</subject><subject>Working groups</subject><subject>World Health Organization</subject><issn>0042-9686</issn><issn>1564-0604</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>7TQ</sourceid><sourceid>8BJ</sourceid><sourceid>ALSLI</sourceid><sourceid>DPSOV</sourceid><sourceid>M0C</sourceid><sourceid>M2L</sourceid><sourceid>M2R</sourceid><sourceid>DOA</sourceid><recordid>eNqNk81v00AQxS0EoqVw5IosIRAcEnbX-9kDUqmgRFQC0cB1NVmPna0cb_DaEfnv2ZDQNigS2AdLM7956zerl2VPKRkzruibd5fTMeVjWmitxL3smArJR0QSfj87JoSzkZFaHmWPYrwm6TGcPMyOmCiUVpIdZ246x_yiCTNo8u_gnG8xv4IK-3U-aX3vofcrPM2xnUObmnW-2kHLOXQLcGHla9-kHuYOluB8GoQ-d2Fo-26dN7jC5nH2oIIm4pPd9yT79uH99Pzj6PLzxeT87HLkNJH9CMrKscqJgkkliDLElJoyI5kizFXIlTEMndMlEK0lVY7JjTdgYiaF0qI4ySZb3TLAtV12fgHd2gbw9nchdLWFrveuQVtQU4EwbDYzhNNZqQVqaZATLJ1OJyWtt1ut5TBbpCImO9Dsie53Wj-3dVhZzogWSiWBVzuBLvwYMPZ24aPDJu0KwxAtlcwUimpa_BsVyS5RmtCEPv8LvQ5D16atJirthGshzS1VQ_Lq2yqkX3QbUXtWaFVwVYjNsaMDVI0tJj-hxcqn8h4_PsCnt8SFdwcHXu8NJKbHn30NQ4z205fJf7OTq6_77Ms77Byh6ecxNEPvQxsPOnRdiLHD6ub-KLGb9NiUHku53aYn8c_uXvoN_ScuCXixAyA6aKpuE4p4y2nNtKCk-AVirRwW</recordid><startdate>20140901</startdate><enddate>20140901</enddate><creator>MAURE, Christine G</creator><creator>DODOO, Alexander N</creator><creator>BONHOEFFER, Jan</creator><creator>ZUBER, Patrick L. F</creator><general>Organisation mondiale de la santé</general><general>World Health Organization</general><general>The World Health Organization</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>ISR</scope><scope>KPI</scope><scope>0-V</scope><scope>3V.</scope><scope>7RV</scope><scope>7T2</scope><scope>7TQ</scope><scope>7WY</scope><scope>7WZ</scope><scope>7X7</scope><scope>7XB</scope><scope>87Z</scope><scope>88C</scope><scope>88E</scope><scope>88J</scope><scope>8AF</scope><scope>8AO</scope><scope>8BJ</scope><scope>8C1</scope><scope>8FE</scope><scope>8FG</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8FL</scope><scope>8G5</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ALSLI</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BEC</scope><scope>BENPR</scope><scope>BEZIV</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DHY</scope><scope>DON</scope><scope>DPSOV</scope><scope>DWQXO</scope><scope>FQK</scope><scope>FRNLG</scope><scope>FYUFA</scope><scope>F~G</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>JBE</scope><scope>K60</scope><scope>K6~</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>KC-</scope><scope>L.-</scope><scope>L6V</scope><scope>M0C</scope><scope>M0R</scope><scope>M0S</scope><scope>M0T</scope><scope>M1P</scope><scope>M2L</scope><scope>M2O</scope><scope>M2R</scope><scope>M7S</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PATMY</scope><scope>PQBIZ</scope><scope>PQBZA</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>Q9U</scope><scope>S0X</scope><scope>7TA</scope><scope>8FD</scope><scope>JG9</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20140901</creationdate><title>The Global Vaccine Safety Initiative: enhancing vaccine pharmacovigilance capacity at country level</title><author>MAURE, Christine G ; DODOO, Alexander N ; BONHOEFFER, Jan ; ZUBER, Patrick L. F</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c806t-adfc2fc53267507909d812962702cfe47992ecc8da088617c269686a25b657853</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Adverse Drug Reaction Reporting Systems</topic><topic>Biological and medical sciences</topic><topic>Collaboration</topic><topic>Communities</topic><topic>Diseases</topic><topic>Dosage and administration</topic><topic>General aspects</topic><topic>Global Health</topic><topic>Health</topic><topic>Health surveillance</topic><topic>High income</topic><topic>Humans</topic><topic>Hypothesis testing</topic><topic>Immunization</topic><topic>Immunization Programs</topic><topic>Medical sciences</topic><topic>Miscellaneous</topic><topic>Patient Safety</topic><topic>Pharmacovigilance</topic><topic>Prevention and actions</topic><topic>Product safety</topic><topic>Public health</topic><topic>Public health. Hygiene</topic><topic>Public health. Hygiene-occupational medicine</topic><topic>Quality management</topic><topic>Regulation</topic><topic>Safety</topic><topic>Strategy</topic><topic>Strengthening</topic><topic>Studies</topic><topic>Surveillance</topic><topic>Vaccines</topic><topic>Vaccines - standards</topic><topic>Working groups</topic><topic>World Health Organization</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>MAURE, Christine G</creatorcontrib><creatorcontrib>DODOO, Alexander N</creatorcontrib><creatorcontrib>BONHOEFFER, Jan</creatorcontrib><creatorcontrib>ZUBER, Patrick L. F</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Science in Context</collection><collection>Global Issues in Context</collection><collection>ProQuest Social Sciences Premium Collection【Remote access available】</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database (ProQuest)</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>PAIS Index</collection><collection>ABI/INFORM Collection</collection><collection>ABI/INFORM Global (PDF only)</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ABI/INFORM Collection</collection><collection>Healthcare Administration Database (Alumni)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Social Science Database (Alumni Edition)</collection><collection>STEM Database</collection><collection>ProQuest Pharma Collection</collection><collection>International Bibliography of the Social Sciences (IBSS)</collection><collection>Public Health Database (Proquest)</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ABI/INFORM Collection (Alumni Edition)</collection><collection>Research Library (Alumni Edition)</collection><collection>Materials Science &amp; Engineering Collection</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>Social Science Premium Collection</collection><collection>Agricultural &amp; Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>eLibrary</collection><collection>ProQuest Central</collection><collection>ProQuest Business Premium Collection</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>PAIS International</collection><collection>PAIS International (Ovid)</collection><collection>Politics Collection</collection><collection>ProQuest Central</collection><collection>International Bibliography of the Social Sciences</collection><collection>Business Premium Collection (Alumni)</collection><collection>Health Research Premium Collection</collection><collection>ABI/INFORM Global (Corporate)</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>International Bibliography of the Social Sciences</collection><collection>ProQuest Business Collection (Alumni Edition)</collection><collection>ProQuest Business Collection</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>ProQuest Politics Collection</collection><collection>ABI/INFORM Professional Advanced</collection><collection>ProQuest Engineering Collection</collection><collection>ABI/INFORM Global</collection><collection>Consumer Health Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Health Management Database (Proquest)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Political Science Database</collection><collection>Research Library</collection><collection>Social Science Database</collection><collection>Engineering Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Environmental Science Database</collection><collection>One Business</collection><collection>ProQuest One Business (Alumni)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Engineering Collection</collection><collection>Environmental Science Collection</collection><collection>ProQuest Central Basic</collection><collection>SIRS Editorial</collection><collection>Materials Business File</collection><collection>Technology Research Database</collection><collection>Materials Research Database</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Bulletin of the World Health Organization</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>MAURE, Christine G</au><au>DODOO, Alexander N</au><au>BONHOEFFER, Jan</au><au>ZUBER, Patrick L. F</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The Global Vaccine Safety Initiative: enhancing vaccine pharmacovigilance capacity at country level</atitle><jtitle>Bulletin of the World Health Organization</jtitle><addtitle>Bull World Health Organ</addtitle><date>2014-09-01</date><risdate>2014</risdate><volume>92</volume><issue>9</issue><spage>695</spage><epage>696</epage><pages>695-696</pages><issn>0042-9686</issn><eissn>1564-0604</eissn><coden>BWHOA6</coden><abstract>Large-scale immunization programmes now extend to all parts of the world, including least developed countries, where they reach unprecedented numbers of people. The number of vaccine doses administered worldwide continues to increase as new vaccines are developed and made available, and more people have access to immunization services. Development of immunization programmes in low- and middle-income countries (LMIC) has increased immunization coverage, which in turn has led to a reduction in vaccine-preventable diseases. However, as vaccine use has increased in LMICs, so has public attention to vaccine safety issues, as happened previously in high-income countries. The Decade of Vaccines aims to increase coordination within the vaccine community worldwide. The Global Vaccine Action Plan includes a vaccine safety strategy, the Global Vaccine Safety Blueprint. Capacity development at country level is the main guiding principle of the Global Vaccine Safety Initiative. The initiative is aligned with other related WHO capacity-building efforts, including the strengthening of immunization programmes and national regulatory authorities.</abstract><cop>Genève</cop><pub>Organisation mondiale de la santé</pub><pmid>25378762</pmid><doi>10.2471/BLT.14.138875</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0042-9686
ispartof Bulletin of the World Health Organization, 2014-09, Vol.92 (9), p.695-696
issn 0042-9686
1564-0604
language eng
recordid cdi_doaj_primary_oai_doaj_org_article_319fa592bb9041bd85e869e40edc8479
source International Bibliography of the Social Sciences (IBSS); Social Science Premium Collection; ABI/INFORM Global; Politics Collection; PAIS Index; PubMed Central
subjects Adverse Drug Reaction Reporting Systems
Biological and medical sciences
Collaboration
Communities
Diseases
Dosage and administration
General aspects
Global Health
Health
Health surveillance
High income
Humans
Hypothesis testing
Immunization
Immunization Programs
Medical sciences
Miscellaneous
Patient Safety
Pharmacovigilance
Prevention and actions
Product safety
Public health
Public health. Hygiene
Public health. Hygiene-occupational medicine
Quality management
Regulation
Safety
Strategy
Strengthening
Studies
Surveillance
Vaccines
Vaccines - standards
Working groups
World Health Organization
title The Global Vaccine Safety Initiative: enhancing vaccine pharmacovigilance capacity at country level
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-23T19%3A03%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20Global%20Vaccine%20Safety%20Initiative:%20enhancing%20vaccine%20pharmacovigilance%20capacity%20at%20country%20level&rft.jtitle=Bulletin%20of%20the%20World%20Health%20Organization&rft.au=MAURE,%20Christine%20G&rft.date=2014-09-01&rft.volume=92&rft.issue=9&rft.spage=695&rft.epage=696&rft.pages=695-696&rft.issn=0042-9686&rft.eissn=1564-0604&rft.coden=BWHOA6&rft_id=info:doi/10.2471/BLT.14.138875&rft_dat=%3Cgale_doaj_%3EA387347353%3C/gale_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c806t-adfc2fc53267507909d812962702cfe47992ecc8da088617c269686a25b657853%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1561748569&rft_id=info:pmid/25378762&rft_galeid=A387347353&rfr_iscdi=true